Galectin Therapeutics GALT
NASDAQ GALT
$3.29 -0.09 (-2.66%)
At close: Nov 11, 2026 · 4:00 PM EST

Galectin Therapeutics (GALT) Goodwill (2021 - 2026)

Updated

Analysis

Galectin Therapeutics (GALT) Goodwill (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Galectin Therapeutics 224.13 Mn 167.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66.31 Bn
Jun 30, 2025 64.06 Bn
Mar 31, 2025 63.29 Bn
Jun 30, 2024 1.72 Mn
Mar 31, 2024 62.15 Bn
Jun 30, 2023 1.72 Mn
Mar 31, 2023 1.72 Mn
Dec 31, 2022 1.72 Mn
Mar 31, 2022 1.72 Mn
Dec 31, 2021 1.72 Mn
Mar 31, 2021 1.72 Mn
API Access

Galectin Therapeutics Goodwill API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill&ticker=GALT&period=max&api_key=YOUR_API_KEY